WallStreetZenWallStreetZen

NASDAQ: BNOX
Bionomics Limited Stock

Overview
ForecastEarningsRevenueDividendOwnership
$0.30+0.01 (+3.45%)
Updated Dec 6, 2024
BNOX Price
$0.30
Fair Value Price
$0.79
Market Cap
$6.31M
52 Week Low
$0.18
52 Week High
$1.60
P/E
N/A
P/B
0.57x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.34
Operating Cash Flow
N/A
Beta
0.62
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BNOX Overview

Bionomics Ltd is a clinical-stage biopharmaceutical company focused on drug candidates to transform the lives of patients suffering from serious central nervous system disorders. The company's lead candidate, BNC210, is a treatment for Social Anxiety Disorder and Post-Traumatic Stress Disorder. Bionomics was incorporated in 1996 and is based in Eastwood, Australia.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine BNOX's potential to beat the market

Zen Rating Component Grades

N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
BNOX
RankedUnranked of 554

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Rigel Pharmaceuticals (RIGL)
$25.45A
Chromadex (CDXC)
$6.72A
Adma Biologics (ADMA)
$19.82A
View Top Biotech Stocks

Be the first to know about important BNOX news, forecast changes, insider trades & much more!

BNOX News

Overview

Due Diligence Score

–
Industry Average (23)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BNOX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BNOX ($0.30) is undervalued by 62.23% relative to our estimate of its Fair Value price of $0.79 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BNOX ($0.30) is significantly undervalued by 62.23% relative to our estimate of its Fair Value price of $0.79 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
BNOX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more BNOX due diligence checks available for Premium users.

Valuation

BNOX fair value

Fair Value of BNOX stock based on Discounted Cash Flow (DCF)

Price
$0.30
Fair Value
$0.79
Undervalued by
62.10%
BNOX ($0.30) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BNOX ($0.30) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

BNOX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
0x
Industry
-105.55x
Market
29.86x

BNOX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.57x
Industry
5.68x
BNOX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BNOX's financial health

Profit margin

Revenue
$0.0
Net Income
-$555.0k
Profit Margin
0%

Assets to liabilities

Assets
$15.8M
Liabilities
$4.0M
Debt to equity
0.34
BNOX's short-term assets ($5.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BNOX's short-term assets ($5.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BNOX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.1M
Investing
$0.0
Financing
-$156.8k

BNOX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
BNOX–$6.31M+4.91%N/A0.57x
VIRX–$6.28M+1.28%-0.14x-0.95x
PPBT–$6.36M+17.25%N/A0.22x
CTCX–$6.38M-6.44%0.34x-1.57x
ADXN–$6.41M+8.23%145.54x0.52x
View Top Biotech Stocks

Bionomics Limited Stock FAQ

What is Bionomics Limited's quote symbol?

(NASDAQ: BNOX) Bionomics Limited trades on the NASDAQ under the ticker symbol BNOX. Bionomics Limited stock quotes can also be displayed as NASDAQ: BNOX.

If you're new to stock investing, here's how to buy Bionomics Limited stock.

What is the 52 week high and low for Bionomics Limited (NASDAQ: BNOX)?

(NASDAQ: BNOX) Bionomics Limited's 52-week high was $1.60, and its 52-week low was $0.18. It is currently -81.31% from its 52-week high and 68.93% from its 52-week low.

How much is Bionomics Limited stock worth today?

(NASDAQ: BNOX) Bionomics Limited currently has 3,514,922,864 outstanding shares. With Bionomics Limited stock trading at $0.30 per share, the total value of Bionomics Limited stock (market capitalization) is $6.31M.

Bionomics Limited stock was originally listed at a price of $14.73 in Dec 16, 2021. If you had invested in Bionomics Limited stock at $14.73, your return over the last 2 years would have been -97.97%, for an annualized return of -85.75% (not including any dividends or dividend reinvestments).

How much is Bionomics Limited's stock price per share?

(NASDAQ: BNOX) Bionomics Limited stock price per share is $0.30 today (as of Dec 6, 2024).

What is Bionomics Limited's Market Cap?

(NASDAQ: BNOX) Bionomics Limited's market cap is $6.31M, as of Dec 8, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bionomics Limited's market cap is calculated by multiplying BNOX's current stock price of $0.30 by BNOX's total outstanding shares of 3,514,922,864.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.